CIK 0001994702
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Kyverna Therapeutics, Inc.
Sign in to watch- Ticker
- KYTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831365441
- Phone
- +1 510-925-2492
- Business address
- 5980 HORTON STREET, SUITE 200, EMERYVILLE, CA
- Former names
- Kyverna Therapeutics, Inc.
- 4 Open-market buy 10% owner bought 133,333 shares at $7.50 ($999,998)
- 4 Planned sale Chief Technology Officer sold 23,998 shares at $12.20 ($292,776)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 16,634 shares (grant or award)
- 4 Grant or award Director acquired 16,634 shares (grant or award)
- 4 Grant or award Director acquired 16,634 shares (grant or award)
- 4 Grant or award Director acquired 16,634 shares (grant or award)
- 4 Grant or award Director acquired 16,634 shares (grant or award)
- 4 Grant or award Director acquired 16,634 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Financial Officer acquired 12,000 shares (grant or award)
- 4 Grant or award Chief Technology Officer acquired 13,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 4 · 68 filings